AAE-PHARMA LIMITED

Company Registration Number:
13654369 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2023

Period of accounts

Start date: 01 October 2022

End date: 30 September 2023

AAE-PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

AAE-PHARMA LIMITED

Company Information

for the Period Ended 30 September 2023




Director: Ahmed Elmi
Registered office: 339
North End Road
London
England
SW6 1NN
Company Registration Number: 13654369 (England and Wales)

AAE-PHARMA LIMITED

Directors' Report Period Ended 30 September 2023

The directors present their report with the financial statements of the company for the period ended 30 September 2023

Directors

The directors shown below have held office during the whole of the period from 01 October 2022 to 30 September 2023
Ahmed Elmi

This report was approved by the board of directors on 14 March 2024
And Signed On Behalf Of The Board By:

Name: Ahmed Elmi
Status: Director

AAE-PHARMA LIMITED

Profit and Loss Account

for the Period Ended 30 September 2023


2023
£

2022
£
Turnover 65,422 -
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 34,500 ) -
Staff Costs ( 9,000 ) -
Depreciation and Writeoffs ( 9,000 ) -
Other charges ( 11,622 ) -
Tax on Profit ( 800 ) -
Profit or (Loss) for Period 500 0

AAE-PHARMA LIMITED

Balance sheet

As at 30 September 2023


2023
£

2022
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 15,000 19,811
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 13,500 ) ( 16,384 )
Net current assets (liabilities): 1,500 3,427
Total assets less current liabilities: 1,500 3,427
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 500 ) ( 0 )
Accruals and deferred income: ( 500 ) ( 0 )
Total net assets (liabilities): 500 3,427
Capital and reserves: 500 3,427

AAE-PHARMA LIMITED

Balance sheet continued

For the year ending 30 September 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 14 March 2024
And Signed On Behalf Of The Board By:

Name: Ahmed Elmi
Status: Director

The notes form part of these financial statements

AAE-PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2023

  • 1. Employee Information

    Average number of employees: 0

AAE-PHARMA LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2023

  • 2. Off balance sheet disclosure

    No